Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of RejuvenAir System Radial Spray Cryotherapy to Determine Safety and Delayed Histological Effect in the Lung

NCT02483052 is registered in ClinicalTrials.gov with CSA Medical, Inc. as lead sponsor.

NCT NCT02483052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02483052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of RejuvenAir System Radial Spray Cryotherapy to Determine Safety and Delayed Histological Effect in the Lung
Lead sponsor
CSA Medical, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2015
Completion date
February 29, 2016
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasms, pulmonary neoplasms